miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN

Citations of this article
Mendeley users who have this article in their library.

This article is free to access.


Background: Cutaneous squamous cell carcinoma (CSCC) is a common type of skin malignancy. MicroRNA-221 (miRNA-221) is a critical non-coding RNA in tumor initiation and progression. However, the molecular mechanisms of miRNA-221 in the development of CSCC remain unknown. This study investigated the expression of miRNA-221 in CSCC and its potential tumor biological functions. Methods: MTT assay, colony assay, PCR, and Western blot were adopted. Results: In this study, miRNA-221 expression was significantly higher in CSCC tissues and cell lines than in normal tissues and cells (P < 0.05). Further functional experiments indicated that miRNA-221 knockdown inhibited the proliferation and cell cycle, while upregulation of miRNA-221 presented the opposite role. The dual reporter gene assays indicated that PTEN is a direct target gene of miRNA-221. PTEN protein or mRNA levels were decreased after the cells were transfected with miR-221 mimics. Conclusions: Taken together, the obtained results indicated that miR-221 plays an oncogenic function in CSCC by targeting PTEN and further suggest that miR-221 may be a potential target for CSCC diagnosis and treatment.




Gong, Z. H., Zhou, F., Shi, C., Xiang, T., Zhou, C. K., Wang, Q. Q., … Gao, S. F. (2019). miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cellular and Molecular Biology Letters, 24(1). https://doi.org/10.1186/s11658-018-0131-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free